USPH U.S. Physical Therapy Inc.

U.S. Physical Therapy Completes First Acquisition of 2017

U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics, announced that the Company has just completed the acquisition of a physical therapy practice that owns and operates 17 clinics and manages an additional 8 clinics. USPH acquired a 70% interest with the practice’s clinical owners retaining 30%. The purchase price was $11.4 million.

The business generates approximately $11 million in total annual revenue. There are approximately 101,000 annual patient visits at owned clinics with revenue of $7.2 million. Revenue from management contracts and other sources is approximately $3.8 million.

Chris Reading, U.S. Physical Therapy Chief Executive Officer, said, “We are very pleased to complete this acquisition with another highly capable and talented group of partners in a market which is wide open for us. We firmly believe that with our support and additional resources that they can continue in their legacy of performing excellent clinical work while further growing and scaling this partnership.”

About U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. operates 557 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages 29 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups.

More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into this press release.

EN
03/01/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on U.S. Physical Therapy Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Downgrading Utilities and Staples to Market Weight We are starting to see some positive signals that suggest the lows for this bear market may have already been established, or at the very least, that additional downside is limited from here. At the same time, the S&P 500 remains in a 4-month downtrend, and the Russell 2000 (IWM) and Russell Micro-Caps (IWC) remain in 8.5-month downtrends. We need to see these indexes reverse their downtrends (get above 4030-4040 on SPX, $189 on IWM, and $115 o...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Breakout Brewing? With the 3200-3230 support level holding strong on the S&P 500, we remain constructive over the intermediate-term as outlined in our 11/3/20 Compass. Considering current market dynamics we see eventual decisive breakouts as the most likely outcome for the major averages, which justifies our positive outlook. At the same time, with the S&P 500, Russell 2000, and Nasdaq 100 climbing 7-12% in just over a week and all three testing logical resistance, we believe there is potential...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch